We’ll be at BioJapan 2025 🇯🇵 — Booth B-81, Deep Tech Canada pavilion. Meet us to talk #GenerativeAI for #DrugDiscovery. Book via the partnering platform or email [email protected]. More info: hubs.ly/Q03HmNk30

Our Head of Drug Discovery, Peter Guzzo will present a poster at the upcoming Discovery On Target in Boston: “Discovery of Novel Dual EGFR/FGFR1 Inhibitors via AI-Driven Design and Synthesis” 📩 Schedule a meeting: [email protected] #BostonDOT #DrugDiscovery #GenerativeAI

🇨🇦🇰🇷 Variational AI is part of the Canadian delegation to the Canada-Korea AI x Life Sciences Innovation Forum! Brian Atwood, PhD will be in Seoul Sept 23–25 for #AIinPharma collaboration talks. #AIDD #GenerativeAI #CanadaKorea

Designing selective dual inhibitors is a real challenge! We are partnering with Life Chemicals and used #GenerativeAI to design novel EGFR/FGFR1 inhibitors. Read more: hubs.ly/Q03JTwYt0 #DrugDiscovery #AIinPharma #SmallMolecules #AIDD

Variational AI is heading to Vienna 🇦🇹 for #BIOEurope 2025! Nov 3–5, we’ll join 5,700+ global biotech & pharma leaders to discuss #GenerativeAI in #DrugDiscovery. Let’s connect: [email protected] #AIDD

Heading to Discovery on Target? Don’t miss Peter Guzzo presenting our poster showcasing our collaboration with Life Chemicals using #GenerativeAI to identify selective dual EGFR/FGFR1 inhibitors. Reach [email protected] to connect! #BostonDOT25 #AIinPharma #DrugDiscovery

We’re excited to announce a new #collaboration with Merck (MSD). We will apply our Enki™ platform, fine-tuned on Merck’s proprietary data, to generate and optimize novel #smallmolecule candidates. Read the PR 👉 hubs.ly/Q03Ktg7H0 #GenerativeAI #AIinPharma #AIDD

$349M potential deal value! That’s the scale of our collaboration with Merck (MSD), announced last week. Read more 👉 hubs.ly/Q03LnrmM0 #GenerativeAI #DrugDiscovery #AIinPharma #Biotech #Pharma #AIDD

Team Variational AI is heading to Yokohama next week for the BioJapan 🇯🇵 Reach [email protected] to meet about #GenerativeAI enhancing #SmallMolecule #DrugDiscovery! #AIDD #BioJapan2025

Yesterday at the Life Sciences BC awards ceremony, Variational AI received the recognition of being the Emerging Company of the Year 🎉 hubs.ly/Q03M7SK70

Attending #BIOEurope? If you’re in #SmallMolecule #DrugDiscovery or starting a new program, Variational AI can help you identify new Leads with generative AI. Let’s connect on the partnering platform 🔗 hubs.ly/Q03MfzPd0

We’re in Yokohama for #BioJapan 2025 as part of the 🇨🇦 #DeepTechCanada delegation! Great discussions on how our #GenerativeAI platform is reshaping #SmallMolecule #DrugDiscovery. See where to meet us next 👉 hubs.ly/Q03MTwN90

Our collaboration with Merck (MSD) shows what’s possible with Enki™. Contact [email protected] to try it now! Learn more about the collaboration: hubs.ly/Q03Np14s0 #DrugDiscovery #GenerativeAI #AIinPharma #AIDD

We’re joining the 10th Annual #LSBCInvest — connecting top innovators, investors & leaders shaping BC’s #Biotech and #Pharma future. Don’t miss your chance — limited spots left! 🔗 hubs.ly/Q03NZcf00 #GenerativeAI #DrugDiscovery #AIDD #Innovation

We’re heading to Frontiers Health event (#FH25) in Berlin 🇩🇪! Variational AI joins “From Molecule to Market,” a masterclass with 7 Canadian AI innovators 🇨🇦 — in partnership with the Canadian Trade Commissioner Service. 🗓️ Nov 11 | 2:30–4:00 PM CET 🔗 hubs.ly/Q03PnwMY0

From 12,000+ startups to just 50 - Variational AI joins CB Insights’ 2025 #DigitalHealth50 🎉 Grateful to see our #GenerativeAI for #DrugDiscovery recognized among the innovators shaping the future of #TechBio. 🔗 hubs.ly/Q03PPDf60

BC’s innovation ecosystem turns deep research into global impact — and we’re proud to be part of it. Thanks BC Trade+Investment for highlighting our #GenerativeAI work in #smallmolecule #DrugDiscovery. 🔗 hubs.ly/Q03PqlVX0

Heading to #BIOEurope in Vienna? 🇦🇹 Our Variational AI team — Peter Guzzo & Valentin Beuchillot — will be there to discuss how #AIDD is reshaping small molecule #DrugDiscovery. Let’s meet up 👋 🔗 hubs.ly/Q03PqggL0

We took home the BIOTECanada Award at the LSBCinvest event, presented by Lumira Ventures. Our CTO, Jason Rolfe showcased Enki, our #GenerativeAI platform for small molecule #DrugDiscovery, highlighting how it can transform early stages of R&D. 🔗 hubs.ly/Q03QGdFD0

Team Variational AI is at BIO Europe in Vienna 🇦🇹! Pete Guzzo & Valentin Beuchillot are meeting biotechs and pharmas to discuss how #GenerativeAI accelerates early-stage #DrugDiscovery. Let’s connect if you’re here!